StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3067% below fair value
$8.32−0.60 (-6.73%)

Close on Nov 20, 2026Market cap $570.55MP/E –Yield –

QuidelOrtho shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

QuidelOrtho's shares outstanding was 69M at Sep 27, 2026. For fiscal 2025 it was 68M, up 0.9% from the year before. The highest annual figure on record is 68M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 28, 202568M+0.9%
FY2024Dec 29, 202467M+0.6%
FY2023Dec 31, 202367M+16.4%
FY2022Jan 1, 202357M+33.8%
FY2021Jan 2, 202243M-1.6%
FY2020Jan 3, 202144M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 202669M+1.0%
Q2 FY2026Jun 28, 202668M+0.9%
Q1 FY2026Mar 29, 202668M+1.0%
Q4 FY2025Dec 28, 202568M+0.9%
Q3 FY2025Sep 28, 202568M+1.0%
Q2 FY2025Jun 29, 202568M+0.9%
Q1 FY2025Mar 30, 202568M+0.9%
Q4 FY2024Dec 29, 202468M+1.0%
Q3 FY2024Sep 29, 202467M+0.6%
Q2 FY2024Jun 30, 202467M+0.4%
Q1 FY2024Mar 31, 202467M-0.3%
Q4 FY2023Dec 31, 202367M-0.3%
Q3 FY2023Oct 1, 202367M-0.9%
Q2 FY2023Jul 2, 202367M+26.3%
Q1 FY2023Apr 2, 202367M+58.3%
Q4 FY2022Jan 1, 202367M+51.9%
Q3 FY2022Oct 2, 202268M+58.8%
Q2 FY2022Jul 3, 202253M+24.8%
Q1 FY2022Apr 3, 202242M–
Q4 FY2021Jan 2, 202244M–
Q3 FY2021Oct 3, 202143M–
Q2 FY2021Jul 4, 202142M–

More QuidelOrtho figures

See a number that looks wrong?